Our core directives are good corporate governance and policies that reflect our values and business goals.
Randolph Renasci
CEO
Welcome to Phenoma Biotech Corporation. Our company is focused on being a leader in the burgeoning industry of phytocannabinoid based health treatments in the form of non-psychoactive consumables and topicals for both human and animal consumption. It is of the utmost importance to us that our innovative brands have full regulatory approval and are well understood by health care providers and consumers. This relatively new industry is quickly finding its way and we believe a firm must have good corporate governance to succeed in the long term. We take very serious our responsibilities in the area of ethical and transparent business practices and building value for our shareholders. As I draw from my extensive experience with implementation of organizational strategies, market entry management and strategic brand development combined with single-minded focus and enthusiasm, I foresee exponential growth for our company this decade. Even with the regulatory environment changing rapidly for the better we are not without obstacles. The near future will be enthralling for our company's development as we attain regulatory approval and launch our innovative brands.
Collaboration with our production and research partners assures our brands thrive.
Working closely with our production partners provides us complete vertical integration and access to the highest quality phytocannabinoids. From US Farm Bill Compliant farms growing non-GMO hemp cultivars high in phytocannabinoids to state-of-the-art extraction facilities with unique chromatography extraction technology and final product processing and packaging all in one facility.
We're proud of our partnerships.
Farms & Genetics
Our partner's network of hemp farms are located throughout the USA in states that have a US Farm Bill-compliant program. These are some of the largest hemp farms in the the USA. Only non-GMO plants with proprietary genetics high in CBD, CBG, CBN, CBC, and other naturally occurring synergistic cannabis compounds are grown.
Before and after each harvest, farmers test the plant material to ensure the absence of pesticides, heavy metals, molds, or mildews. After testing is completed, farmers then process and ship the phytocannabinoid-rich plant material to our partner's extraction facilities where the biomass is processed into full spectrum oil or isolate. Once converted, each batch is then assigned a unique barcode and certified at a testing lab before being shipped to our partner's GMP manufacturing facility to be made into premium phytocannabinoid-rich finished products.
All products conform to the regulations of the 2014 and 2018 US Farm Bills section 7606 which Federally legalized the cultivation of Registered United States Industrial Hemp under certain conditions to which all of our supply chain partners fully comply.
Processing Facilities
Our production partner's 300,000 sq. ft. facility accommodates any type of extraction, formulation, blending, filling and packaging we require. This high speed and high precision plant has production capabilities of up to 400,000 units per day along with blend & fill capabilities for numerous product types including Surfactant, Emulsions, Gels, Oils, and Alcohol-based formulas. Also, 20 filling lines accommodating container sizes ranging from 0.33 oz to over 1 gallon and machinery to fill packets, pouches, bottles, tubs, jars, tubes, pails and drums.
Research and development happens in a dedicated 12,000 sq.ft. facility with the ability to perform all critical testing and preservatory efficacy (PET) for each formulation. The proprietary extraction and purification process removes unwanted THC and chlorophyll leaving intact the full spectrum profile of non-psychoactive phytocannabinoids and synergistic compounds. On site chromatography and third party testing assures the highest quality Hemp Derived Phytocannabinoid-Rich oil extracts with no solvents, heavy metals nor pesticides.
